Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Pfizer’s Celsentri (maraviroc), an important new HIV medicine and the first new oral class of HIV treatment in more than a decade, has been made available for treatment experienced patients in the UK. Discovered and developed by Pfizer scientists in Sandwich, Kent, maraviroc represents a significant innovation in the treatment of HIV infection.


Previous Article Next Article

Today in Medical Devices/Products...keeping you current

Medical Calculators: Online Tool for Pediatricians
Indian Pediatrics, 06/30/09

Teva Announces Approval and Launch of Tri-Lo Sprintec Tablets
Teva Pharmaceutical Industries, 07/02/09

Prevalence and Characteristics of Vibrator Use by Women in the United States: Results from a Nationally Representative Study
The Journal of Sexual Medicine, 05/13/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address